Welcome to our Evotec Blog.

Hope you will find our articles and resources relevant for your projects and interests.

Our experts are available for any additional information and to assist with your project challenges!

Just contact us.




Evotec AG announces first nine-month 2017 results and corporate update
Laura Catalina, 8 November 2017

Strong operational and financial performance Expansion of leading external innovation platform through acquisition of aptuit Important milestone achievements and new ways of accelerating innovation Hamburg, Germany, 08 November 2017: Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) today reported financial results and...

Evotec joins forces with Academic Leaders to accelerate Drug Discovery in kidney diseases and build “Neplex”
Laura Catalina, 7 November 2017

Collaboration aimed at developing novel “Nephron-on-a Chip” device to test drug candidates in human kidney: NEPLEX (“Nephron-on-a-Chip with Cellular and Extracellular Matrix Complexity”) Major step forward to the next generation Kidney Platform Hamburg, Germany, 06 November 2017:Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN:...

Evotec AG to report first nine-month 2017 results on 08 November 2017
Laura Catalina, 2 November 2017

Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) will report its financial results for the first nine months of 2017 on Wednesday, 08 November 2017. The Company is going to hold a conference call to discuss the results as well as to provide an update on its performance. The conference call will be held in English. Conference...



Contact us


Business Development

T +44.(0)1235.86 15 61 T +1.732 329 2355 x3308